Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Christine Clavero-Fabri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|April 17, 2004
[Colorectal cancer management]Philippe Rougier, Marie-Christine Clavero-Fabri, Emmanuel Mitry
Gastroenterologie Clinique Et Biologique|January 20, 2005
[Ovarian adenocarcinoma, primary or metastasic tumour of an adenocarcinoma of the colon: the role of molecular biology]Nicolas Goasguen, Catherine Julié, Jean-Nicolas Vaillant, et al.
Gastroenterologie Clinique Et Biologique|August 24, 2002
[5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer]Julien Taïeb, Thierry Lecomte, Joël Ezenfis, et al.
Oncology|March 9, 2007
Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trialIsabelle Borget, Anne Aupérin, Jean-Pierre Pignon, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|April 17, 2004
[Colorectal cancer management]Philippe Rougier, Marie-Christine Clavero-Fabri, Emmanuel Mitry
Gastroenterologie Clinique Et Biologique|January 20, 2005
[Ovarian adenocarcinoma, primary or metastasic tumour of an adenocarcinoma of the colon: the role of molecular biology]Nicolas Goasguen, Catherine Julié, Jean-Nicolas Vaillant, et al.
Gastroenterologie Clinique Et Biologique|August 24, 2002
[5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer]Julien Taïeb, Thierry Lecomte, Joël Ezenfis, et al.
Oncology|March 9, 2007
Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trialIsabelle Borget, Anne Aupérin, Jean-Pierre Pignon, et al.
Pageof 1